Berlin, Germany – As antibiotic resistance accelerates into a global crisis, phage therapy is emerging as one of the most promising—and urgent—solutions in modern medicine. From June 10–11, 2025, the international scientific and medical community will gather in Berlin for Targeting Phage Therapy 2025, the leading global event focused on translating phage research into clinical reality.
With the theme “ From Bench to Bedside: Accelerating Clinical Applications of Phage Therapy ”, this year’s program brings together global leaders across infectious diseases, oncology, microbiome science, regulatory affairs, and biotechnology.
Strategic Aim: Clinical Implementation of Phage Therapy
This year’s edition is strategically designed to fast-track the integration of phage-based therapeutics into routine clinical practice. Key sessions will explore:
“The field has matured. The science is here. Now, our focus is clear: scale up production, secure regulatory approval, and deliver precision phage therapies to the patients who need them,” says Prof. Marvin Edeas, Chairman of the Scientific Committee.
Highlights from the 2025 Program – Major Speakers Include:
"Keynote Speech – Phage Therapy 2030: Getting from here to there"
"Bacteriophage Therapy: A Renaissance – From Military Medicine to Civilian Healthcare"
"Complex Phage Communities Control Gut (im)balances and May Hold the Key to Restore Gut Biosis"
"Inhaled Bacteriophage Therapy for Multidrug Resistant Pseudomonas Aeruginosa: Advances & Perspectives"
"KlebPhaCol: Novel Gut Phage Order Associated with the Human Gut"
"Optimizing the Phage-Bacteria Ratio in Phage Therapy: Metagenomic Insights into Microbial Balance and Dysbiosis"
"Phage Defense Systems: Are they an Obstacle for Phage Therapy?"
"Biocontrol of Phage Resistance in Pseudomonas Infections – Fitness Trade-Offs Between Phages and Antibiotic Sensitivity"
"Yersinia Phage Stories: Impact on Phage Therapy"
"Targeting Tumors with Engineered Phages: A New Frontier in Precision Oncology"
"Engineering Phages for Cancer Therapy: Insights into Immune Interactions and Targeting in Ex-Vivo and In-Vivo Models"
"Endolysin B as a New Approach & Archetype in M. Tuberculosis Treatment"
"Ex vivo pig lung as a new Cystic Fibrosis model for the study of Pseudomonas aeruginosa biofilm infection and phage therapy application"
"Translating Phage Therapy into the Clinic: Recent Accomplishments and Next Challenges"
"Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery"
"Phage Therapy in Veterinary Medicine: Presentation of First Clinical Trial in Japan"
"Bacteriophages Applications in Broiler Farms: Strategies & Perspectives"
"Phage Therapy in Europe: Legal, Regulatory and Ethic Issues"
Among the companies who will attend the congress:
Jafral (Supporter)
Amazon
Apothekendienstleistungen
Aptar Radolfzell GmbH
Centro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana
ArGe Teknoloji Sanayi ve Ticaret Anonim Şirketi
FagoFarma
TiPHAGE
Grachtenhaus-Apotheke e.K.
German Collection of Microorganisms and Cell Cultures GmbH
Inteliphage
Kanzlei BRENNER
Komplementäre Tiermedizin GmbH
LABOKLIN GmbH & Co. KG
Laboklin Phage Center
Laboratorios Syva
MB Pharma
MicrobiotiX
Medios AG
Nordmark Pharma
Otsuka Pharmaceutical CO.
Phileo by Lesaffre
Phagos
Precise Health SA
PrecisionPhage
Poulpharm
Qiagen
Rime Bioinformatics
Salem Microbes
A Defining Moment for Antibacterial Innovation
As resistance to antibiotics continues to grow, phage therapy is moving from scientific promise to clinical necessity. With over 75 communications, live discussions, and poster sessions attendees from 27 countires, the event aims to chart the course for clinical access, regulatory harmonization, and global collaborations.
For media inquiries, interviews, or partnership opportunities, visit: www.phagetherapy-site.com
MEDIA KIT
Phage Therapy: The Hottest Frontier in Tomorrow’s Medicine
Targeting Phage Therapy 2025
June 10–11, 2025 – Berlin, Germany
Website: www.phagetherapy-site.com
MEDIA CONTACT
Email: contact@phagetherapy-site.com
EVENT OVERVIEW
Strategic Theme:
“From Bench to Bedside: Accelerating Clinical Applications of Phage Therapy”
EVENT HIGHLIGHTS
PRESS MATERIALS
SOCIAL MEDIA & TAGS
Hashtags:
#PhageTherapy2025 | #Microbiome | #FutureOfMedicine | #PrecisionInfectiousCare
LinkedIn: https://www.linkedin.com/showcase/phage-therapy-task-force/
QUOTES FOR MEDIA USE
“Phage therapy is no longer experimental—it’s strategic. This conference marks the inflection point where science becomes practice.”
— Prof. Marvin Edeas, Chair, Scientific Committee